Lung Panel Articles & Analysis: Older
2 news found
Vancouver, British Columbia – (September 8, 2022) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce today that it’s abstract titled “Metabolomic Profiling for the Early Detection of Lung Cancer” has been ...
ClearSeq AML, the latest product in a series of next-generation sequencing cancer research panels, will also be unveiled at this year's ECP. This panel provides comprehensive coverage of mutations and enables swift progression of sample processing in less than a day. The AML gene panel will be followed in the coming months by the release of ...